Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBRA L RICHARDSON

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1992784987
CMS profile
225765
Location
OKLAHOMA CITY, OK

General Payments · PY2018–2024

$107,503.92

  • Reported across 137 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$33,546.39

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $24,037.50 10
Travel and Lodging $7,946.13 6
Food and Beverage $1,562.76 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genmab U.S., Inc. $11,233.18 8
GlaxoSmithKline, LLC. $9,053.27 4
Karyopharm Therapeutics Inc. $4,129.48 3
Daiichi Sankyo Inc. $2,495.55 3
EISAI INC. $2,445.00 1
ABBVIE INC. $2,269.38 2
Acerta Pharma LLC $1,834.66 4
PFIZER INC. $37.65 1
Astellas Pharma US Inc $22.22 1
Genentech USA, Inc. $14.79 1
Merck Sharp & Dohme Corporation $11.21 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $17,211.48 50
PY2019 $16,152.36 24
PY2020 $3,521.93 5
PY2021 $11,903.55 6
PY2022 $6,800.00 2
PY2023 $18,368.21 21
PY2024 $33,546.39 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $169.38 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105945325 CMS
ABBVIE INC. $2,100.00 07/16/2024 Consulting Fee Undisputed 01/23/2026 1105945327 CMS
Astellas Pharma US Inc $22.22 02/13/2024 Food and Beverage Undisputed 01/23/2026 1139266060 CMS
AstraZeneca Pharmaceuticals LP $68.99 01/26/2024 Food and Beverage Undisputed 01/23/2026 1105682337 CMS
AstraZeneca Pharmaceuticals LP $1,712.50 02/13/2024 Consulting Fee Undisputed 01/23/2026 1105796284 CMS
AstraZeneca Pharmaceuticals LP $38.35 06/02/2024 Food and Beverage Undisputed 01/23/2026 1104203285 CMS
AstraZeneca Pharmaceuticals LP $14.82 11/05/2024 Food and Beverage Undisputed 01/23/2026 1105413134 CMS
Daiichi Sankyo Inc. $1,860.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 1089474463 CMS
Daiichi Sankyo Inc. $15.55 05/08/2024 Food and Beverage Undisputed 01/23/2026 1089474469 CMS
Daiichi Sankyo Inc. $620.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1089474465 CMS
Eisai Inc. $2,445.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1110741265 CMS
Genentech USA, Inc. $14.79 06/26/2024 Food and Beverage Undisputed 01/23/2026 1133000274 CMS
Genmab U.S., Inc. $7,041.61 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1126825945 CMS
Genmab U.S., Inc. $44.46 12/12/2024 Food and Beverage Undisputed 01/23/2026 1126825935 CMS
Genmab U.S., Inc. $31.87 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1126825937 CMS
Genmab U.S., Inc. $626.71 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1126825939 CMS
Genmab U.S., Inc. $3,275.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1126825941 CMS
Genmab U.S., Inc. $44.29 12/13/2024 Food and Beverage Undisputed 01/23/2026 1126825943 CMS
Genmab U.S., Inc. $139.95 12/15/2024 Travel and Lodging Undisputed 01/23/2026 1126825947 CMS
Genmab U.S., Inc. $29.29 12/15/2024 Travel and Lodging Undisputed 01/23/2026 1126825949 CMS
GlaxoSmithKline, LLC. $2,400.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1115843487 CMS
GlaxoSmithKline, LLC. $2,800.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1116312339 CMS
GlaxoSmithKline, LLC. $1,053.27 07/02/2024 Food and Beverage Undisputed 01/23/2026 1116092091 CMS
GlaxoSmithKline, LLC. $2,800.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1116469692 CMS
Karyopharm Therapeutics Inc. $4,025.00 01/19/2024 Consulting Fee Undisputed 01/23/2026 1145529025 CMS
Karyopharm Therapeutics Inc. $76.70 03/29/2024 Travel and Lodging Undisputed 01/23/2026 1145529021 CMS
Karyopharm Therapeutics Inc. $27.78 09/27/2024 Food and Beverage Undisputed 01/23/2026 1145529028 CMS
Merck Sharp & Dohme LLC $11.21 07/31/2024 Food and Beverage Undisputed 01/23/2026 1141734113 CMS
PFIZER INC. $37.65 09/16/2024 Food and Beverage Undisputed 01/23/2026 1131357669 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.